Brasil
Clinics (1807-5932)
Effects of pemafibrate (a selective PPAR-α agonist) versus weight loss through an intensive lifestyle modification on liver enzymes, serum soluble dipeptidyl peptidase-4, and hepatic steatosis and fibrosis evaluated by FibroScan transient elastography in people with type 2 diabetes and MASLD
3 years
2 years
1 year
all

Document access evolution

Loading
Loading
Loading
This tool is under development and it is available in Beta Test version
This tool is under development and it was published with the objective to test the usage and performance. All the indicators are real and they are gradually being loaded. Slowness and out of service problems may occur in this version.

SciELO - Scientific Electronic Library Online
FAPESP CNPq BIREME FapUnifesp

Avenida Onze de Junho, 269 - Vila Clementino 04041-050 São Paulo

Tel.: +55 11 5083-3639/59 - Email: scielo@scielo.org

Help

Developments

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.